|
General Information
|
|
|
Product
|
E2F5 Peptide
|
|
Description
|
Antigenic Blocking Peptide Transcription Factor E2F5 Antibody
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic peptide
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q61502
|
|
Overview
|
Transcriptional activator that binds to E2F sites, these sites are present in the promoter of many genes whose products are involved in cell proliferation
|
|
Molecular Function
|
DNA binding; sequence-specific DNA binding transcription factor activity.
|
|
Subcellular Location
|
Nucleus
|
|
Expression
|
In the developing epidermis,nervous system;choroid plexus;kidney; liver; lung; heart
|
|
Structure
|
Component of the DRTF1/E2F transcription factor complex
|
|
Alternative Nomenclature
|
E2F 5 antibody
E2F transcription factor 5 antibody
E2F transcription factor 5 p130 binding antibody
p130 binding antibody
|
| |
|
E2F5 Antibody
E2F5 Antibody FITC
E2F5 Antibody BIOTIN
E2F5 Positive Control
